Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia.


The possible synergistic interaction between azidothymidine (AZT) and interferon alpha (rIFN-alpha 2a) in the treatment of chronic myelogenous leukemia (CML) was studied in vitro using marrow or peripheral blood hematopoietic progenitors from 10 patients with CML in the mixed (CFU-GEMM) colony culture assay. Used singly, either agent inhibited erythroid… (More)


  • Presentations referencing similar topics